Thursday, March 08, 2012 8:49:47 AM
Grupo Iusacell DE Cv (NYSE:CEL)
Today : Thursday 8 March 2012
Cellcom Israel Announces Shelf Prospectus Amendment
PR Newswire
NETANYA, Israel, March 8, 2012
NETANYA, Israel, March 8, 2012 /PRNewswire/ --
Cellcom Israel Ltd. (NYSE: CEL) (TASE: CEL) (hereinafter: the "Company") announced today that, following its previous announcements, in preparation for a potential offering of new series of debentures to the public in Israel only, under the Company's shelf prospectus, the Company published today an amendment to the shelf prospectus and indenture filed within such shelf prospectus, or the Amendment, after having received the Israeli Securities Authority, or ISA, and the Tel Aviv Stock Exchange, or TASE, approvals. The amendment to the shelf prospectus includes also an undertaking of the Company to comply with certain reporting obligations under the Israeli securities law that relate to information to be provided to debenture holders (which have not previously applied to the Company pursuant to Israeli law as it is a dual company traded both in Israel and in the US).
The contemplated offering will require filing of a supplemental shelf offering report with the ISA and TASE.
The execution, timing, terms and amount of such contemplated offering have not yet been determined and are subject to a further approval of the Company's Board of Directors. There is no assurance that such offering will be executed, nor as to its timing, terms and amount.
For additional details regarding the Company's public debentures and additional undertakings of the Company included in the Amendment see the Company's annual report on Form 20-F for the year ended December 31, 2011 filed on March 7, 2012, under "Item 5. Liquidity and Capital Resources - Debt Service - Shelf prospectus" and " - Public Debentures".
The contemplated offering described in this press release, will be made, if made, in Israel to residents of Israel only. The said debentures will not be registered under the U.S. Securities Act of 1933 and will not be offered or sold in the United States. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any debentures.
Forward looking statement
The information included in this press release contains, or may be deemed to contain, forward-looking statements (as defined in the U.S. Private Securities Litigation Reform Act of 1995 and the Israeli Securities Law, 1968). Said forward-looking statements, relating to the execution of the offering, the amount to be raised and the use of its proceeds are subject to uncertainties and assumptions about the shelf offering and market conditions and sufficient offers received for an adequate price. The actual conditions could lead to materially different outcome than that set forth above.
About Cellcom Israel
Cellcom Israel Ltd., established in 1994, is the leading Israeli cellular provider; Cellcom Israel provides its approximately 3.349 million subscribers (as at December 31, 2011) with a broad range of value added services including cellular and landline telephony, roaming services for tourists in Israel and for its subscribers abroad and additional services in the areas of music, video, mobile office etc., based on Cellcom Israel's technologically advanced infrastructure. The Company operates an HSPA 3.5 Generation network enabling advanced high speed broadband multimedia services, in addition to GSM/GPRS/EDGE networks. Cellcom Israel offers Israel's broadest and largest customer service infrastructure including telephone customer service centers, retail stores, and service and sale centers, distributed nationwide. Through its broad customer service network Cellcom Israel offers its customers technical support, account information, direct to the door parcel delivery services, internet and fax services, dedicated centers for the hearing impaired, etc. In August 2011, Cellcom Israel completed the acquisition of Netvision Ltd. 013 Netvision Ltd., its wholly owned subsidiary, is a leading Israeli provider of internet connectivity services and international calling services. Cellcom Israel, through its wholly owned subsidiaries also provides landline telephone communication services in Israel, in addition to data communication services. Cellcom Israel's shares are traded both on the New York Stock Exchange (CEL) and the Tel Aviv Stock Exchange (CEL). For additional information please visit the Company's website http://www.cellcom.co.il
Company Contact Yaacov Heen Chief Financial Officer investors@cellcom.co.il Tel: +972-52-998-9755
Investor Relations Contact Porat Saar CCG Investor Relations Israel & US cellcom@ccgisrael.com Tel: +1-646-233-2161
SOURCE Cellcom Israel Ltd.
Recent CEL News
- Celadon hails early results of chronic pain trial • Alliance News • 03/08/2024 08:04:45 PM
- Celadon Pharmaceuticals PLC Early Economic Analysis of Feasibility Study Data • RNS Non-Regulatory • 03/07/2024 07:00:13 AM
- Celadon announces start of cannabis supply for two UK companies • Alliance News • 12/14/2023 02:18:53 PM
- Celadon Pharmaceuticals PLC Product Supplied to First Two Sales Contracts • UK Regulatory • 12/14/2023 07:00:00 AM
- Celadon Pharma raises GBP2.0 million via placing • Alliance News • 12/12/2023 05:40:04 PM
- Celadon Pharmaceuticals PLC Fundraise, Update on Future CLN Financing & TVR • UK Regulatory • 12/12/2023 02:00:00 PM
- Celadon shares rise on supply contract worth up to GBP26 million • Alliance News • 11/16/2023 11:45:35 AM
- Celadon Pharmaceuticals PLC New European Sales Contract • UK Regulatory • 11/16/2023 07:00:00 AM
- Celadon Pharmaceuticals raises GBP1.0 million through shares • Alliance News • 10/13/2023 02:42:26 PM
- Celadon Pharmaceuticals PLC Fundraise, CLN Issue, Joint Broker Appointed & TVR • UK Regulatory • 10/13/2023 06:00:00 AM
- Celadon Pharmaceuticals interim loss narrows; optimistic for future • Alliance News • 09/28/2023 11:14:47 AM
- Celadon Pharmaceuticals PLC Interim Results • UK Regulatory • 09/28/2023 06:00:00 AM
- Celadon Pharmaceuticals PLC Notice of Results and Investor Presentation • UK Regulatory • 09/18/2023 06:00:00 AM
- Celadon shares rise on second UK contract win for cannabis product • Alliance News • 09/05/2023 09:48:42 AM
- Celadon Pharmaceuticals PLC New Sales Contract with UK Pharmaceutical Company • UK Regulatory • 09/05/2023 06:00:00 AM
- Celadon receives approval for 5,000 patient clinical cannabis trial • Alliance News • 08/01/2023 10:44:46 AM
- Celadon Pharmaceuticals PLC Approval to roll-out chronic pain clinical trial • UK Regulatory • 08/01/2023 06:00:00 AM
- Celadon Pharmaceuticals PLC Result of AGM • UK Regulatory • 06/29/2023 04:30:00 PM
- Celadon Pharmaceuticals PLC Publication of Annual Report and Notice of AGM • UK Regulatory • 06/05/2023 01:46:00 PM
- Celadon Pharmaceuticals loss widens; confident amid three-year deal • Alliance News • 06/05/2023 11:23:05 AM
- Celadon Pharmaceuticals PLC Final Results for the year ended 31 December 2022 • UK Regulatory • 06/05/2023 06:00:00 AM
- Celadon secures GBP7 million credit facility as product demand grows • Alliance News • 05/30/2023 10:56:00 AM
- Celadon Pharmaceuticals PLC GBP7 Million Committed Credit Facility • UK Regulatory • 05/30/2023 06:00:00 AM
- Celadon Pharmaceuticals PLC Notice of Results and Investor Presentation • UK Regulatory • 05/26/2023 06:00:00 AM
- Celadon Pharmaceuticals PLC West Midlands Mayor Visits Celadon's Facility • RNS Non-Regulatory • 05/25/2023 06:00:00 AM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM